The scrutiny centers on claims that Gildan’s reported revenue growth masked a multi-year decline in organic performance. Jehoshaphat Research alleged that the Canadian company utilized financial engineering to obscure these underlying losses, prompting the firm to disclose a short position in the stock. Rosen Law Firm is currently organizing a class action lawsuit to seek recovery for investors who suffered losses during this period.

The firm, led by Laurence Rosen and Phillip Kim, is encouraging shareholders to join the prospective litigation. Investors can participate through a contingency fee arrangement, which requires no out-of-pocket costs. Those interested in the investigation or seeking to join the class action are directed to the firm’s website or requested to contact Phillip Kim directly via phone or email.